Wilms' tumor 1 protein and estrogen receptor beta expression are associated with poor outcomes in uterine carcinosarcoma
- PMID: 23344579
- DOI: 10.1245/s10434-012-2838-9
Wilms' tumor 1 protein and estrogen receptor beta expression are associated with poor outcomes in uterine carcinosarcoma
Abstract
Background: Uterine carcinosarcoma (CS) is an aggressive malignancy. Increased expression of Wilms' tumor 1 (WT1) protein and estrogen receptor beta (ER-β) protein is associated with worse outcomes in gynecologic cancers; therefore, we sought to assess this association in CS patients.
Methods: A retrospective analysis was conducted for women diagnosed with uterine CS from departmental databases. WT1/ER-β expression was determined by immunohistochemical staining and scoring of specimens. Univariate and multivariate models were used to correlate progression-free survival (PFS) and overall survival (OS) with WT1/ER-β expression and clinicopathologic factors.
Results: Ninety four patients had mean follow-up of 27 months. Postoperative treatments included chemotherapy for 52 (55 %) subjects and radiotherapy for 25 (27 %). Sixty-four (68 %) and 74 (79 %) tumor samples expressed WT1 and ER-β by immunohistochemistry, respectively. On univariate analysis, stage (p = .02) and lower uterine segment invasion (LUSI) (p = .001) were associated with decreased PFS. Only stage (p = .003) was linked to OS. In the total sample, increased WT1 expression was marginally associated with impaired PFS (p = .07) and OS (p = .09) but ER-β expression was not associated with PFS (p = .89) or OS (p = .30). WT1 and ER-β concurrent expression was associated with impaired OS (p = .02) and PFS (p = .02). On multivariate analysis, LUSI was a significant prognostic factor for PFS [hazard ratio (HR) 2.21, 95 % confidence interval (CI) = 1.12-4.32, p = .03] and stage for OS (HR 3.20, 95 % CI = 1.23-8.35, p = .02). Increased WT1/ER-β expression was associated with impaired OS (HR 1.31, 95 % CI = 1.02-1.69, p = .04).
Conclusions: Concurrent increased WT1 and ER-β expression impairs prognosis for women with uterine CS. Further research is warranted to define how relevant pathways interact and whether targeting these pathways improves OS.
Similar articles
-
A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.Gynecol Oncol. 2015 Nov;139(2):275-82. doi: 10.1016/j.ygyno.2015.09.002. Epub 2015 Sep 6. Gynecol Oncol. 2015. PMID: 26348313 Free PMC article.
-
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.Gynecol Oncol. 2011 Dec;123(3):548-52. doi: 10.1016/j.ygyno.2011.08.020. Epub 2011 Sep 25. Gynecol Oncol. 2011. PMID: 21945551
-
Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.Gynecol Oncol. 2001 Oct;83(1):89-94. doi: 10.1006/gyno.2001.6334. Gynecol Oncol. 2001. PMID: 11585418
-
Rare uterine cancer: carcinosarcomas. Review from histology to treatment.Crit Rev Oncol Hematol. 2015 Apr;94(1):98-104. doi: 10.1016/j.critrevonc.2014.10.013. Epub 2014 Nov 7. Crit Rev Oncol Hematol. 2015. PMID: 25468677 Review.
-
Diagnosis of recurrent uterine carcinosarcoma by fine-needle aspiration cytology: report of a case.Diagn Cytopathol. 2000 Aug;23(2):108-13. doi: 10.1002/1097-0339(200008)23:2<108::aid-dc9>3.0.co;2-o. Diagn Cytopathol. 2000. PMID: 10888756 Review.
Cited by
-
Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.Sci Rep. 2015 Mar 9;5:8924. doi: 10.1038/srep08924. Sci Rep. 2015. PMID: 25748047 Free PMC article.
-
WT1: The Hinge Between Anemia Correction and Cancer Development in Chronic Kidney Disease.Front Cell Dev Biol. 2022 Apr 6;10:876723. doi: 10.3389/fcell.2022.876723. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35465313 Free PMC article. Review.
-
Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma.Neoplasia. 2017 Feb;19(2):100-111. doi: 10.1016/j.neo.2016.12.009. Epub 2017 Jan 12. Neoplasia. 2017. PMID: 28088687 Free PMC article.
-
Diagnostic and Prognostic Role of WT1 Immunohistochemical Expression in Uterine Carcinoma: A Systematic Review and Meta-Analysis across All Endometrial Carcinoma Histotypes.Diagnostics (Basel). 2020 Aug 26;10(9):637. doi: 10.3390/diagnostics10090637. Diagnostics (Basel). 2020. PMID: 32859123 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical